Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Exagen Inc.
Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record Performance
August 05, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 02, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
August 01, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Second Quarter 2024 Results on August 5, 2024
July 22, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
May 13, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Announces Campaign for Lupus Awareness Month
May 06, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce First Quarter 2024 Results on May 13, 2024
April 30, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Announces Changes to the Board of Directors
April 26, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results
March 18, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
March 08, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024
March 07, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 30, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 07, 2024
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong Third Quarter 2023 Results
November 13, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers
November 09, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
November 02, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
October 30, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting
September 28, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
September 12, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Strong Second Quarter 2023 Results
August 07, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 26, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023
July 25, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Appoints Paul Kim to Board of Directors
July 24, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
FLGT
XGN
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
May 30, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports First Quarter 2023 Results
May 15, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Announces Campaign for Lupus Awareness Month
May 01, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023
April 24, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
March 20, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
March 06, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Exagen Inc. to Participate in Upcoming March Conferences
February 27, 2023
From
Exagen Inc.
Via
GlobeNewswire
Tickers
XGN
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit